Journal Mobile Options

Vol. 62, Suppl. 1, 2002

Issue release date: 2002

Researching Hepatocellular Carcinoma in Japan: A Message to the World

Tokyo, July 2000

See also ISBN 978-3-8055-7328-3 for more details
Select / Unselect all
Special Section
I

Title Page / Table of Contents / Editorial Committee

Oncology 2002;62(suppl 1):I–V (DOI:10.1159/000048266)
Free Access
1

Preface

Iino S.
Oncology 2002;62(suppl 1):1 (DOI:10.1159/000048267)
Free Access
 
2

Leading-Edge Research Studies of Hepatocellular Carcinoma in Japan

Oda T.
Oncology 2002;62(suppl 1):2–4 (DOI:10.1159/000048268)
5

Characteristics of Hepatocellular Carcinoma in Japan

Kiyosawa K. · Tanaka E.
Oncology 2002;62(suppl 1):5–7 (DOI:10.1159/000048269)
8

Hepatocellular Carcinoma Associated with Hepatitis C Virus Infection in Japan: Projection to Other Countries in the Foreseeable Future

Yoshizawa H.
Oncology 2002;62(suppl 1):8–17 (DOI:10.1159/000048270)
18

Natural History of Hepatitis B and C Virus Infections

Iino S.
Oncology 2002;62(suppl 1):18–23 (DOI:10.1159/000048271)
24

Current Strategies for Chemoprevention of Hepatocellular Carcinoma

Okito K. · Sakaida I. · Hino K.
Oncology 2002;62(suppl 1):24–28 (DOI:10.1159/000048272)
29

Molecular Mechanism of Viral Hepatocarcinogenesis

Koike K. · Tsutsumi T. · Fujie H. · Shintani Y. · Moriya K.
Oncology 2002;62(suppl 1):29–37 (DOI:10.1159/000048273)
38

Molecular Aspects of Human Hepatocarcinogenesis Mediated by Inflammation: From Hypercarcinogenic State to Normo- or Hypocarcinogenic State

Umeda T. · Hino O.
Oncology 2002;62(suppl 1):38–42 (DOI:10.1159/000048274)
43

Pathological Evolution of Early Hepatocellular Carcinoma

Kojiro M.
Oncology 2002;62(suppl 1):43–47 (DOI:10.1159/000048275)
48

Imaging Blood Flow Characteristics of Hepatocellular Carcinoma

Kudo M.
Oncology 2002;62(suppl 1):48–56 (DOI:10.1159/000048276)
57

Tumor Markers in Early Diagnosis, Follow-Up and Management of Patients with Hepatocellular Carcinoma

Fujiyama S. · Tanaka M. · Maeda S. · Ashihara H. · Hirata R. · Tomita K.
Oncology 2002;62(suppl 1):57–63 (DOI:10.1159/000048277)
64

Nonsurgical Treatment of Hepatocellular Carcinoma: From Percutaneous Ethanol Injection Therapy and Percutaneous Microwave Coagulation Therapy to Radiofrequency Ablation

Shiina S. · Teratani T. · Obi S. · Hamamura K. · Koike Y. · Omata M.
Oncology 2002;62(suppl 1):64–68 (DOI:10.1159/000048278)
69

Combination Chemotherapy for Advanced Hepatocellular Carcinoma Complicated by Major Portal Vein Thrombosis

Kaneko S. · Urabe T. · Kobayashi K.
Oncology 2002;62(suppl 1):69–73 (DOI:10.1159/000048279)
74

Progress in Surgical Treatment of Hepatocellular Carcinoma

Makuuchi M. · Imamura H. · Sugawara Y. · Takayama T.
Oncology 2002;62(suppl 1):74–81 (DOI:10.1159/000048280)
82

Liver Transplantation as a Therapeutic Option for Hepatocellular Carcinoma

Matsunami H. · Shimizu Y. · Lynch S.V. · Balderson G.A. · Ando Y. · Strong R.W.
Oncology 2002;62(suppl 1):82–86 (DOI:10.1159/000048281)
87

Interferon for Decreasing the Incidence of Hepatocellular Carcinoma in Patients with Chronic Hepatitis C

Hayashi N. · Kasahara A.
Oncology 2002;62(suppl 1):87–93 (DOI:10.1159/000048282)
94

Long-Term Treatment of Chronic Hepatitis C with Glycyrrhizin [Stronger Neo-Minophagen C (SNMC)] for Preventing Liver Cirrhosis and Hepatocellular Carcinoma

Kumada H.
Oncology 2002;62(suppl 1):94–100 (DOI:10.1159/000048283)
101

A Message to Japan

Tanikawa K.
Oncology 2002;62(suppl 1):101–102 (DOI:10.1159/000048284)
103

A Message to Asia

Suzuki H.
Oncology 2002;62(suppl 1):103–104 (DOI:10.1159/000048285)
Further Section
105

Author Index

Oncology 2002;62(suppl 1):105 (DOI:10.1159/000048286)
Free Access
106

Subject Index

Oncology 2002;62(suppl 1):106 (DOI:10.1159/000048287)
Free Access